• 6 min read
• Published on 25 July 2025
Hey! We are Nemo.
Nemo, short for Never Miss Out, is a mobile investment platform that delivers curated, data-driven investment ideas to your fingertips. It offers commission-free trading across stocks, ETFs, crypto, and CFDs, along with AI-powered tools, real-time market alerts, and themed stock collections called Nemes.
Download the App
Scan the QR code to download the Nemo app and start investing on Nemo today
published-on
Read article
published-on
Read article
published-on
Read article
published-on
Read article
published-on
Read article
View the full Basket:Patient Builders
Let’s be honest, shall we. The modern market feels a bit like a frantic lottery. Everyone is chasing the next explosive stock, the crypto that will supposedly make you a millionaire overnight, or some tech firm that promises to change the world before it has even turned a profit. It’s exhausting, and frankly, a bit silly. I find myself increasingly drawn to a far less glamorous, but potentially more rewarding, way of thinking. I’m talking about the patient builders, the corporate tortoises to the market’s hares.
View the full Basket:Patient Builders
What on earth is a patient builder? To me, it’s a company that thinks in decades, not in quarterly earnings reports. Take Microsoft. I remember when it was just the company that made Windows. Instead of sitting on that cash cow until it ran dry, it methodically, almost painstakingly, reinvented itself as a cloud computing titan. There was no sudden, flashy pivot. It was a slow, deliberate grind that has made it one of the most formidable businesses on the planet.
This is the art of building a proper competitive moat. Not with a single clever idea, but with years of reinvesting profits, improving operations, and earning customer trust. It requires a kind of discipline that seems almost alien today. Management has to resist the urge to chase fleeting trends, and investors have to resist the urge to get bored. It might not give you a thrilling story to tell at the pub, but a steadily growing portfolio could be a decent consolation prize.
View the full Basket:Patient Builders
This philosophy is perhaps best seen in the giants of healthcare and consumer goods. A company like Johnson & Johnson didn't become a household name by accident. For over a century, it has balanced the high-risk, high-reward world of pharmaceuticals with the steady, reliable business of selling things like plasters and baby shampoo. One side funds the moonshots, the other keeps the lights on. It’s a masterclass in resilience.
The same goes for Procter & Gamble. Building brands like Tide or Pampers takes an immense amount of time and money. It’s a slow, expensive process of earning a permanent spot in a shopper’s brain. Many companies would slash their marketing budgets at the first sign of trouble, but these patient builders understand that a trusted brand is an asset that pays dividends for generations. It’s the difference between building a solid brick house and a trendy, flat-pack shed that might not survive the winter.
View the full Basket:Patient Builders
When markets get choppy and uncertainty is the only certainty, where does money tend to go? It often flows towards quality and predictability. Investors, it seems, suddenly remember the value of a strong balance sheet and a business model they can actually understand. This is where the patient builders may truly shine. Their financial prudence means they often carry less debt and have the cash to keep investing when their more reckless competitors are forced to pull back. It’s this kind of thinking that informs collections like the Patient Builders basket, which groups together these types of steady operators.
Of course, let’s not get carried away. This strategy is not a magic bullet. These companies can, and do, underperform, especially when the market is in a full-blown bull run and everyone else is making a fortune on speculative bets. "Boring" can feel rather frustrating when high-growth stocks are soaring. And even the biggest giants are not immune to disruption or their own strategic blunders. Investing always carries risk, and a patient approach doesn’t change that fundamental truth. It simply asks for a different kind of temperament from the investor, one that values slow compounding over a quick thrill.
View the full Basket:Patient Builders
View the full Basket:Patient Builders
View the full Basket:Patient Builders
View the full Basket:Patient Builders
View the full Basket:Patient Builders
View the full Basket:Patient Builders
This article is marketing material and should not be construed as investment advice. No information set out in this article be considered, as advice, recommendation, offer, or a solicitation, to buy or sell any financial product, nor is it financial, investment, or trading advice. Any references to specific financial product or investment strategy are for illustrative / educational purposes only and subject to change without notice. It is the investor’s responsibility to evaluate any prospective investment, assess their own financial situation, and seek independent professional advice. Past performance is not indicative of future results. Please refer to our Risk Disclosure.
published-on
Read article
published-on
Read article
published-on
Read article
published-on
Read article
published-on
Read article